Yasin N, Veenman L, Singh S, Azrad M, Bode J, Vainshtein A, Caballero B, Marek I, Gavish M. Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling. Int J Mol Sci. 18: pii: E786, 2017
Chen Y, Veenman L, Singh S, Ouyang F, Liang J, Huang W, Marek I, Zeng J, Gavish M. 2-Cl-MGV-1 Ameliorates Apoptosis in the Thalamus and Hippocampus and Cognitive Deficits After Cortical Infarct in Rats. Stroke. 2017;48(12):3366-3374.
Yasin N, Veenman L, Dimitrova-Shumkovska J, Moshe Gavish M. The 18 kDa translocator protein, non-coding RNA, and homeostasis. NCRI 2017;1:25 doi: 10.21037/ncri.2017.12.02
Gavish M, Veenman L. Regulation of Mitochondrial, Cellular, and Organismal Functions by TSPO. Adv Pharmacol. 2018;82:103-136.
Rosenberg N, Rosenberg O, Weizman A, Veenman L, Gavish M. In vitro Effects of the Specific Mitochondrial TSPO Ligand Ro5 4864 in Cultured Human Osteoblasts. Exp Clin Endocrinol Diabetes. 2018;126:77-84.
Nahum Rosenberg N, Nasra Yasin N, Leo Veenman , Orit Rosenberg O, Weizman A, Gavish M. 18 kDa Translocator Protein in Mitochondria-Related Pathology: The Case of Traumatic Brain Injury. In : (Editors; Eylem Taskin, Celal Guven, Yusuf Sevgiler) Mitochondrial Diseases 2018; Chapter 9 pp 228 -235 IntechOpen http://dx.doi.org/10.5772/intechopen.74057
Azrad M, Zeineh N, Weizman A, Veenman L, Gavish M. The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS. Int J Mol Sci. 2019 Jan 30;20(3). pii: E594.
Zeineh N, Nagler R, Gabay M, Weizman A, Gavish M. Effects of Cigarette Smoke on TSPO-related Mitochondrial Processes. Cells. 2019 Jul 10;8(7). pii: E694.
Monga S, Nagler R, Amara R, Weizman A, Gavish M. Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation. Cells. 2019 May 22;8(5). pii: E486.
Monga S, Weizman A, Gavish M. The Efficacy of the Novel TSPO Ligands 2-Cl-MGV-1 and 2,4-Di-Cl-MGV-1 Compared to the Classical TSPO Ligand PK 11195 to Counteract the Release of Chemokines from LPS-Stimulated BV-2 Microglial Cells. Biology (Basel). 2020 Sep 14;9(9):291. doi: 10.3390/biology9090291. PMID: 32938018; PMCID: PMC7565396.
Seelu Monga, Nunzio Denora, Valentino Laquintana, Massimo Franco, Ilan Marek, Sukhdev Singh, Rafi Nagler, Abraham Weizman, Moshe Gavish, The protective effect of the TSPO ligands 2,4-Di-Cl-MGV-1, CB86, and CB204 against LPS-induced M1 pro-inflammatory activation of microglia, Brain, Behavior, & Immunity - Health, Volume 5, 2020,100083, ISSN 2666-3546, https://doi.org/10.1016/j.bbih.2020.100083.
Kahana M, Weizman A, Gabay M, Loboda Y, Segal-Gavish H, Gavish A, Barhum Y, Offen D, Finberg J, Allon N, Gavish M. Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson's disease. Mol Psychiatry. 2020 May 5. doi: 10.1038/s41380-020-0742-4. Epub ahead of print. PMID: 32372010.